Divergence in Fitness and Evolution of Drug Resistance in Experimental Populations of Candida albicans
暂无分享,去创建一个
[1] D. Andersson,et al. The cost of antibiotic resistance from a bacterial perspective. , 2000, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[2] Richard E. Lenski,et al. Long-Term Experimental Evolution in Escherichia coli. II. Changes in Life-History Traits During Adaptation to a Seasonal Environment , 1994, The American Naturalist.
[3] S. Paulous,et al. Resistance of human immunodeficiency virus type 1 to protease inhibitors: selection of resistance mutations in the presence and absence of the drug. , 1996, The Journal of general virology.
[4] K. Crandall,et al. Parallel evolution of drug resistance in HIV: failure of nonsynonymous/synonymous substitution rate ratio to detect selection. , 1999, Molecular biology and evolution.
[5] S. Levy. Balancing the drug-resistance equation. , 1994, Trends in microbiology.
[6] E. Anaissie. Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] B. Levin,et al. The biological cost of antibiotic resistance. , 1999, Current opinion in microbiology.
[8] E. Bruck,et al. National Committee for Clinical Laboratory Standards. , 1980, Pediatrics.
[9] M Travisano,et al. Long-term experimental evolution in Escherichia coli. IV. Targets of selection and the specificity of adaptation. , 1996, Genetics.
[10] S. Wright. Surfaces of Selective Value Revisited , 1988, The American Naturalist.
[11] P. T. Magee,et al. Recent developments in molecular genetics of Candida albicans. , 2000, Annual review of microbiology.
[12] R. Anderson,et al. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[13] M. Milgroom,et al. Lack of correlation between fitness and resistance to sterol biosynthesis-inhibiting fungicides in Pyrenophora teres , 1994 .
[14] B. Levin,et al. Compensatory mutations, antibiotic resistance and the population genetics of adaptive evolution in bacteria. , 2000, Genetics.
[15] R. Lenski,et al. Long-Term Experimental Evolution in Escherichia coli. I. Adaptation and Divergence During 2,000 Generations , 1991, The American Naturalist.
[16] T. C. White,et al. Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance , 1998, Clinical Microbiology Reviews.
[17] P. Melgarejo,et al. Fitness of Botrytis cinerea Associated with Dicarboximide Resistance. , 2000, Phytopathology.
[18] J. E. Bouma,et al. Evolution of a bacteria/plasmid association , 1988, Nature.
[19] J. Bull,et al. Mice Are Not Furry Petri Dishes , 2000, Science.
[20] T. Leitner,et al. Stochastic processes strongly influence HIV-1 evolution during suboptimal protease-inhibitor therapy. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[21] L. Cowen,et al. Evolution of Drug Resistance in Experimental Populations of Candida albicans , 2000, Journal of bacteriology.
[22] M. Ghannoum,et al. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Labora , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[23] T. O'Brien,et al. The global epidemic nature of antimicrobial resistance and the need to monitor and manage it locally. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[24] C. Paquin,et al. Relative fitness can decrease in evolving asexual populations of S. cerevisiae , 1983, Nature.
[25] Sewall Wright,et al. CHARACTER CHANGE, SPECIATION, AND THE HIGHER TAXA , 1982, Evolution; international journal of organic evolution.
[26] A. F. Bennett,et al. Experimental tests of the roles of adaptation, chance, and history in evolution. , 1995, Science.
[27] N. Georgopapadakou,et al. Human mycoses: drugs and targets for emerging pathogens. , 1994, Science.
[28] N. Georgopapadakou,et al. Antifungals: mechanism of action and resistance, established and novel drugs. , 1998, Current opinion in microbiology.
[29] O. Berg,et al. Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance. , 2000, Science.
[30] S. Levy,et al. The impact of antibiotic use on resistance development and persistence. , 2000, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[31] R. Korona. Genetic divergence and fitness convergence under uniform selection in experimental populations of bacteria. , 1996, Genetics.
[32] F. Cohan,et al. AMELIORATION OF THE DELETERIOUS PLEIOTROPIC EFFECTS OF AN ADAPTIVE MUTATION IN BACILLUS SUBTILIS , 1994, Evolution; international journal of organic evolution.
[33] S. Levin,et al. Disease transmission dynamics and the evolution of antibiotic resistance in hospitals and communal settings. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[34] M. D. Waard,et al. Fitness of isolates of Erysiphe graminis f.sp. tritici with reduced sensitivity to fenpropimorph. , 1996 .
[35] B. Levin,et al. Adaptation to the fitness costs of antibiotic resistance in Escherichia coli , 1997, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[36] T. C. White,et al. The Trailing End Point Phenotype in Antifungal Susceptibility Testing Is pH Dependent , 1999, Antimicrobial Agents and Chemotherapy.
[37] R. Lenski,et al. The cost of antibiotic resistance--from the perspective of a bacterium. , 2007, Ciba Foundation symposium.
[38] R. Lenski,et al. Dynamics of adaptation and diversification: a 10,000-generation experiment with bacterial populations. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[39] F. M. Stewart,et al. The population genetics of antibiotic resistance. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[40] C. Boucher,et al. Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy. , 1999, AIDS.
[41] T. G. Mitchell,et al. Clonal and Spontaneous Origins of Fluconazole Resistance in Candida albicans , 2000, Journal of Clinical Microbiology.
[42] P. T. Magee,et al. Single-Copy IMH3 Allele Is Sufficient To Confer Resistance to Mycophenolic Acid in Candida albicans and To Mediate Transformation of Clinical Candida Species , 2001, Infection and Immunity.
[43] J. Rex,et al. Resistance of Candida species to fluconazole , 1995, Antimicrobial agents and chemotherapy.